No CrossRef data available.
Article contents
The Oxford Handbook of US Health Law IG Cohen, AK Hoffman and WM Sage (eds) Oxford: Oxford University Press, 2017, 1232pp
Published online by Cambridge University Press: 23 January 2020
Abstract
- Type
- Book Review
- Information
- Copyright
- © Cambridge University Press 2020
References
1 Although some of the chapters do take at least a partial historical lens. See eg IG Cohen, “The Relationship between Bioethics and US Health Law: Past, Present and Future”, pp 29–48.
2 For example, both Medicaid and Medicare have specific chapters devoted to them. See TR Marmor and J Oberlander, “Medicare at Fifty”, pp 742–764 and S Rosenbaum, “Medicaid at Fifty”, pp 765–786.
3 AR Moncrieff and J Lawless, “Healthcare Federalism”, pp 93–113.
4 AK Hoffman, “What Health Reform Reveals about Health Law”, pp 49–69.
5 WM Sage, “Relating Health Law to Health Policy: A Frictional Account”, pp 3–28.
6 Cohen, supra, note 1.
7 C Flood and B Thomas, “A View from a Friend and a Neighbor: A Canadian Perspective on US Healthcare and the Affordable Care Act”, pp 70–92.
8 F Pasquale, “Health Information Law”, pp 193–212.
9 S Hoffman, “Medical Privacy and Security”, pp 267–287.
10 E Sepper, “Conscientious Refusals of Care”, pp 354–374.
11 BR Furrow, “Medical Malpractice Liability: Of Modest Expansions and Tightening Standards”, pp 421–443.
12 JR Horwitz, “Nonprofit Healthcare Organizations and the Law”, pp 535–555.
13 WM Sage, “Antitrust Enforcement and the Future of Healthcare Competition”, pp 606–636.
14 MA Hall, “Employment-Based Health Coverage”, pp 703–719.
15 AB Monahan, “The Interactions between Public and Private Health Insurance”, pp 787–807.
16 AM Capron, “The Ethics of Rationing Healthcare”, pp 892–913; M Frakes et al, “The Economics of Healthcare Rationing”, pp 914–933.
17 LO Gostin et al, “American Public Health Law”, pp 937–958; Z Lazzarini, “Communicable Disease Law and Emerging Issues: Antibiotic Resistance”, pp 959–982; LF Wiley et al, “Public Health: Noncommunicable Disease Prevention”, pp 983–1007; JG Hodge, Jr, “Public Health Emergency Legal and Ethical Preparedness”, pp 1008–1030.
18 M Barnes and D Peloquin, “The Biomedical Research Enterprise”, pp 585–605.
19 LA Grossman, “Drugs, Biologics and Devices: FDA Regulation, Intellectual Property, and Medical Products in the American Healthcare System”, pp 637–658.
20 MB Kapp, “Aging Population”, pp 1053–1074.
21 WE Parmet, “Who’s In? Immigrants and Healthcare”, pp 1033–1052.
22 There does not appear to be a specific mention in the Handbook as to when its material was collated into a final version but based on a publication date of 2017, it is likely that the text was finalised sometime in 2016.